How cisplatin and gemcitabine work together in cancer cells
Author Information
Author(s): Moorsel C J A van, Pinedo H M, Veerman G, Bergman A M, Kuiper C M, Vermorken J B, van der Vijgh W J F, Peters G J
Primary Institution: Department of Medical Oncology, University Hospital Vrije Universiteit
Hypothesis
The study investigates the synergistic effects of cisplatin and gemcitabine on ovarian and non-small-cell lung cancer cell lines.
Conclusion
The synergism between gemcitabine and cisplatin is primarily due to increased formation of platinum-DNA adducts related to gemcitabine's incorporation into DNA.
Supporting Evidence
- Cisplatin and gemcitabine were found to have synergistic effects in multiple cancer cell lines.
- The combination of these drugs increased DNA damage more than either drug alone.
- Cisplatin significantly enhanced the incorporation of gemcitabine into DNA and RNA.
Takeaway
Cisplatin and gemcitabine can work better together to fight certain cancers by helping each other damage cancer cell DNA more effectively.
Methodology
The study used various combinations of cisplatin and gemcitabine on different cancer cell lines and evaluated synergism through median drug effect analysis.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website